Bula sells WBC 98.84: Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA
1 SAA is a blood disorder where the bone marrow fails to make enough red blood cells, white blood cells and platelets.2 Eltrombopag, an oral thrombopoietin (TPO) receptor agonist, works by helping to induce proliferation and differentiation of bone marrow ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home